|1.95||+0.0500||+2.63%||Vol 269.62K||1Y Perf -96.61%|
|Jul 29th, 2022 16:00 DELAYED|
|- -||- -%|
|Target Price||10.33||Analyst Rating||— — 0.00|
|Potential %||-||Finscreener Ranking||— -|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||— -|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★★★ — -|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Price Range Ratio 52W %||0.14||Earnings Rating||Buy|
|Market Cap||70.49M||Earnings Date||8th Aug 2022|
Today's Price Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||-0.74|
|EPS Growth Next 5 Years %||39.90|
|Avg. Weekly Volume||360.87K|
|Avg. Monthly Volume||513.96K|
|Avg. Quarterly Volume||464.07K|
Cortexyme Inc. (NASDAQ: CRTX) stock closed at 2.07 per share at the end of the most recent trading day (a -3.27% change compared to the prior day closing price) with a volume of 547.12K shares and market capitalization of 70.49M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 23 people. Cortexyme Inc. CEO is Casey C. Lynch.
The one-year performance of Cortexyme Inc. stock is -96.61%, while year-to-date (YTD) performance is -84.55%. CRTX stock has a five-year performance of %. Its 52-week range is between 1.7821 and 121.98, which gives CRTX stock a 52-week price range ratio of 0.14%
Cortexyme Inc. currently has a PE ratio of -0.70, a price-to-book (PB) ratio of 0.74, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -60.90%, a ROC of -67.48% and a ROE of -67.34%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.
Of the last four earnings reports from Cortexyme Inc., there were 0 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.74 for the next earnings report. Cortexyme Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Cortexyme Inc. is — (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Cortexyme Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Cortexyme Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Cortexyme Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 12.72, ATR14 : 0.19, CCI20 : -130.55, Chaikin Money Flow : -0.11, MACD : -0.15, Money Flow Index : 27.05, ROC : -16.53, RSI : 27.13, STOCH (14,3) : 15.00, STOCH RSI : 0.00, UO : 50.58, Williams %R : -85.00), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Cortexyme Inc. in the last 12-months were: Caryn G. McDowell (Sold 10 800 shares of value $30 923 ), Christopher P. Lowe (Option Excercise at a value of $812 041), Christopher P. Lowe (Sold 9 926 shares of value $977 711 ), Margaret McLoughlin (Option Excercise at a value of $17 000), Margaret McLoughlin (Sold 1 000 shares of value $88 930 )
Tue, 22 Mar 2022 10:26 GMT Cortexyme (CRTX) Gets a Buy Rating from H.C. Wainwright- TipRanks. All rights reserved.
Tue, 08 Mar 2022 19:15 GMT Cortexyme (CRTX) Gets a Hold Rating from JMP Securities- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.